Opioid-based Anesthetic Techniques: Considerations for Patient Selection and Perioperative Management Webcast
Release date: April 2, 2013
Expiration date: April 2, 2014
Estimated time to complete activity: 1.0 hour
Jeffrey G. Priest, MD
Central Utah Surgical Center
Significant advances in monitoring, safety systems, and the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of anesthetic agents have contributed to improvements in the safety and effectiveness of general anesthesia. Even with these advances, safe and effective anesthetic practice would not be possible without highly educated and well-trained anesthesiology professionals.
Anesthesiology professionals are responsible for assessing factors that may influence a patient’s outcome during surgery. Appropriate preoperative evaluation and planning are of critical importance to ensure a clinician’s ability to respond intraoperatively to patient response, adjust dosing to maintain intraoperative analgesia, optimize recovery time, and ensure that postoperative adverse events are minimized.
This program will review important considerations for general anesthesia and opportunities for improving perioperative patient management in a case-based format. The effects of particular compounds used as adjuncts to general anesthesia will also be reviewed.
This activity has been designed for anesthesiologists, certified nurse anesthetists, surgeons, nurses, and other healthcare providers involved in the administration of general anesthesia.
Upon completion of this educational activity, participants should be able to:
- Review preanesthesia evaluation and safety procedures
- Describe comparative PK data and PD effects of short-acting opioids used during surgery
- Discuss available techniques for anesthesia and monitoring strategies
- Describe postoperative analgesia strategies to optimize patient outcomes
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty/planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Sean M. Gregory, PhD, hereby states that he and his spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Jeffrey G. Priest, MD
Consultant: Drug Enforcement Agency
Directions to Learners
There are no fees for participating and receiving CME credit for this activity. During the period April 2, 2013 through April 2, 2014, participants must:
- Read the learning objectives and faculty disclosures
- Complete the pretest
- Study the educational activity
- Complete the posttest and the evaluation form
A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Your statement of credit will be sent to you within 4 weeks.
When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)
Minimum System Requirements
Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10
Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Flash Player 10
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Mylan Specialty do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. or Mylan Specialty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Supported by an educational grant from: